Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Cohen who wrote (37)	11/8/1996 9:16:00 AM
From: Dr. John M. de Castro	of 1494

Things at NTII are not as bad as they appear. I've learned that Michael Ostrach has another position. The details haven't been worked out, so it wasn't announced along with the resignation. He has wanted to run his own company for years and this may be a move in that direction. This is just an example of the poor PR job that NTII is doing. It is absolutely amazing to me how a company with a drug that could very well be a $500MM or better drug could have a MV of $25MM. I am heartened by the fact that over the long haul, the quality of the products will speak for themselves. But, on the short term, I guess we're going to have to live with poor handling of PR and its impact on NTII's price and volatility. I also see this as an excellent buy opportunity, but I'm biased as I already own a position in NTII. Do your own research.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next